Arginyl residues are involved in the transport of Fe2+ through the plasma membrane of the mammalian reticulocyte

J Membr Biol. 1994 Sep;141(3):225-30. doi: 10.1007/BF00235131.

Abstract

Sealed reticulocyte ghosts were treated with reagents that modify a variety of amino acid residues. Only ninhydrin and phenylglyoxal, both modifiers of arginyl residues, produced inhibition of the initial rate of 59Fe2+ uptake. The inhibition (i) was dependent on the concentration of ninhydrin or phenylglyoxal, (ii) increased from pH 7 to 9, a feature of the modification of arginine by ninhydrin or phenylglyoxal, and (iii) was blocked when Fe2+ was present during the modification step. A23187, an effective membrane Fe2+ transporter, diminished the inhibitory effect of ninhydrin and phenylglyoxal, indicative that the transport of iron through the membrane, and not a secondary process, was selectively inhibited. We conclude that the iron transporter from the plasma membrane of erythroid cells has one or more arginyl residues in a segment accessible to ninhydrin or phenylglyoxal, and that this residue is involved in the transmembrane transport of iron.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginine*
  • Biological Transport / drug effects
  • Calcimycin / pharmacology
  • Erythrocyte Membrane / drug effects
  • Erythrocyte Membrane / metabolism*
  • Hydrogen-Ion Concentration
  • Iron / blood*
  • Iron Radioisotopes
  • Kinetics
  • Mammals
  • Ninhydrin / pharmacology
  • Phenylglyoxal / pharmacology
  • Reticulocytes / metabolism*
  • Valinomycin / pharmacology

Substances

  • Iron Radioisotopes
  • Valinomycin
  • Calcimycin
  • Arginine
  • Iron
  • Ninhydrin
  • Phenylglyoxal